Previously treated cases tested for RR-/MDR-TB in Kyrgyzstan

Kyrgyzstan: Previously treated cases tested for RR-/MDR-TB was 95.0% in 2024. ▲ Rising

Latest (2024)
95.0%
Change on year
up 3.3%
World rank
66th
of 180 countries
All-time high
95.0%
in 2019
All-time low
17.0%
in 2006
Years of data
18
2005–2024

Previously treated cases tested for RR-/MDR-TB in Kyrgyzstan, 2005–2024

204060801002005201420242005: 182006: 172007: 192008: 432009: 352010: 272012: 782013: 742015: 502016: 472017: 562018: 942019: 952020: 942021: 952022: 932023: 922024: 95

Source: World Health Organization, Global Health Observatory.

Analysis

Kyrgyzstan recorded 95.0% for previously treated cases tested for rr-/mdr-tb in 2024. That is the highest value across all 18 years on record.

That represents a change of up 3.3% on the previous year and up 28.4% over ten years.

Over the whole period, previously treated cases tested for rr-/mdr-tb in Kyrgyzstan peaked at 95.0% in 2019 and was at its lowest, 17.0%, in 2006.

That places Kyrgyzstan 66th out of 180 countries with data for 2024, putting it in the middle of the range.

The long-run direction has been consistently rising across the 18 years of available data.

Previously treated cases tested for RR-/MDR-TB in Kyrgyzstan, year by year

Annual values for Previously treated cases tested for RR-/MDR-TB (%) in Kyrgyzstan, 2005 to 2024.
Year Value Change
2005 18.0%
2006 17.0% -5.6%
2007 19.0% +11.8%
2008 43.0% +126.3%
2009 35.0% -18.6%
2010 27.0% -22.9%
2012 78.0% +188.9%
2013 74.0% -5.1%
2015 50.0% -32.4%
2016 47.0% -6.0%
2017 56.0% +19.1%
2018 94.0% +67.9%
2019 95.0% +1.1%
2020 94.0% -1.1%
2021 95.0% +1.1%
2022 93.0% -2.1%
2023 92.0% -1.1%
2024 95.0% +3.3%

Averages by decade

DecadeAverage LowestHighest Years
2000s 26.4% 17.0% 43.0% 5
2010s 65.1% 27.0% 95.0% 8
2020s 93.8% 92.0% 95.0% 5

Countries ranked near Kyrgyzstan

  1. 65 Macau, China 96.0% compare
  2. 66 Peru 95.0% compare
  3. 66 Chad 95.0% compare
  4. 66 Nigeria 95.0% compare
  5. 66 Uruguay 95.0% compare
  6. 66 Namibia 95.0% compare

See the full ranking of 193 places →

More health data for Kyrgyzstan

All data for Kyrgyzstan →

Frequently asked questions

What is previously treated cases tested for rr-/mdr-tb in Kyrgyzstan?
Previously treated cases tested for rr-/mdr-tb in Kyrgyzstan was 95.0% in 2024, according to World Health Organization, Global Health Observatory.
What is the highest previously treated cases tested for rr-/mdr-tb recorded in Kyrgyzstan?
The highest recorded value was 95.0% in 2019.
What is the lowest previously treated cases tested for rr-/mdr-tb recorded in Kyrgyzstan?
The lowest recorded value was 17.0% in 2006.
How does Kyrgyzstan rank for previously treated cases tested for rr-/mdr-tb?
Kyrgyzstan ranks 66th out of 180 countries with data for 2024.
Is previously treated cases tested for rr-/mdr-tb rising or falling in Kyrgyzstan?
Over the last ten years it is up 28.4%. The long-run trend across the full record is rising.
Where does this Kyrgyzstan data come from?
The figures come from World Health Organization, Global Health Observatory, published as part of Previously treated cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).

Share, cite or embed this page

Cite this page

Previously treated cases tested for RR-/MDR-TB in Kyrgyzstan. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 04 September 2026, from https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/kyrgyz-republic/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/stat/previously-treated-cases-tested-for-rr-mdr-tb-percent/kyrgyz-republic/">Previously treated cases tested for RR-/MDR-TB in Kyrgyzstan</a> — Statizoid

About this data

Indicator
Previously treated cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
193 places, 3,089 data points, 2005–2024
Last refreshed